Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Bacillus Calmette-Guérin (BCG)PDL

Including but not limited to Bacillus Calmette-Guérin (BCG): Strain TICE, Strain Russian BCG-I, when sold or recommended as an antineoplastic agent.

I MAY / 21
Bacillus Calmette-Guérin (BCG) vaccine I FEB / 02
Bacitracin or its salts or derivativesPDL

For veterinary use

I DEC / 18
Bacitracin or its salts or derivatives .

For human use: for parenteral use

I SEP / 98
Bacitracin or its salts or derivatives ..

For human use: for topical use

U SEP / 98
Bacitracin or its salts or derivatives …

For human use: for ophthalmic use

III JUN / 06
Baclofen or its saltsPDL I DEC / 13
Baloxavir marboxilPDL I JUL / 20
Bambuterol or its saltsPDL I DEC / 13
BamlanivimabPDL I NOV / 20
Barbiturates, their salts and derivativesC

Excluding the substances set out in items 6 and 7 of Part I of this schedule (Schedule G of the Food and Drug Regulations), as well as barbituric acid and its salts and 1,3-dimethylbarbituric acid and its salts, but including: Allobarbital; Alphenal; Amobarbital; Aprobarbital; Barbital; Butabarbital; Butalbital; Butallylonal; Butethal; Cyclobarbital; Cyclopal; Heptabarbital; Hexethal; Hexobarbital; Mephobarbital; Methabarbital; Methylphenobarbital; Propallylonal;
Phenobarbital; Probarbital; Phenylmethylbarbituric Acid; Sigmodal; Talbutal; Vinbarbital; Vinylbital
 

I JUN / 02
Baricitinib or its saltsPDL I OCT / 18
BasiliximabPDL I DEC / 13
Bazedoxifene or its saltsPDL I DEC / 14
BecaplerminPDL I DEC / 13
BedinvetmabPDL

For veterinary use

I MAY / 21
BelimumabPDL I DEC / 13
Belladonna alkaloids, and their salts and derivatives except in preparations for topical use or in trace amounts in homeopathic preparations II SEP / 98
BemegridePDL I DEC / 13
Benactyzine or its saltsPDL I DEC / 13
Benazepril or its salts or derivativesPDL

including but not limited to benazepril hydrochloride

I DEC / 13
Bendamustine or its salts or derivativesPDL

including but not limited to bendamustine hydrochloride

I DEC / 13
Bendazac or its saltsPDL I DEC / 13
Benoxaprofen or its saltsPDL I DEC / 13
Benoxinate hydrochloride oxybuprocaine for ophthalmic or parenteral use II SEP / 98
BenralizumabPDL I MAY / 18
Benserazide or its saltsPDL I DEC / 13
Bentiromide II SEP / 98
Benzalkonium and its salts liquid preparations in concentrations of more than 2% II SEP / 98
Benzazocines, their salts, derivatives and salts of derivativesN

Including: Phenazocine, Metazocine, Pentazocine; but not including: Cyclazocine and its salts
 

I JUN / 02
Benzethonium chloride liquid preparations in concentrations of more than 1% II SEP / 98
Benzimidazoles, their salts, derivatives and salts of derivativesN

Including: Clonitazene, Etonitazene 
 

I JUN / 02
Benzocaine and its salts for parenteral or ophthalmic use II SEP / 98
Benzodiazepines, their salts and derivativesTS

Including: Alprazolam, Bromazepam, Brotizolam, Camazepam, Chlordiazepoxide, Clobazam, Clonazepam, Clorazepate, Cloxazolam, Delorazepam, Diazepam, Estazolam, Ethyl Loflazepate, Fludiazepam, Flurazepam, Halazepam, Haloxazolam, Ketazolam, Loprazolam, Lorazepam, Lormetazepam, Medazepam, Midazolam, Nimetazepam, Nitrazepam, Nordazepam, Oxazepam, Oxazolam, Pinazepam, Prazepam, Quazepam, Temazepam, Tetrazepam,  Triazolam; but not including: Clozapine and any salt thereof, Flunitrazepam and any salts or derivatives thereof, Olanzapine and its salts, Clozapine N-oxide and its salts

I SEP / 98
Benzonatate III SEP / 98
Benzoyl peroxidePDL

in concentrations greater than 5% or when sold in combination with another medicinal ingredient

I DEC / 13
Benzoyl peroxide. preparations of 5% or less as a single ingredient U MAY / 08
Benztropine or its saltsPDL

including but not limited to benzatropine

I DEC / 13
Benzydamine or its saltsPDL I DEC / 13
Benzyl benzoate II SEP / 98
Bepotastine or its salts or derivativesPDL I NOV / 16
BeractantPDL I DEC / 13
Besifloxacin or its saltsPDL I DEC / 13
Betahistine or its saltsPDL I DEC / 13
Betaine or its saltsPDL

for human use, when sold or recommended for the treatment of homocystinuria

I DEC / 13
Betaine or its salts.PDL

for veterinary use

I DEC / 13
Betaxolol or its saltsPDL I DEC / 13
Bethanechol chloridePDL I DEC / 13
Bethanidine or its saltsPDL I DEC / 13
BevacizumabPDL I DEC / 13
Bezafibrate or its salts or derivativesPDL I DEC / 13
BicalutamidePDL I DEC / 13
Bictegravir or its saltsPDL I AUG / 18
Bilastine or its salts or derivativesPDL I AUG / 16
Binimetinib or its saltsPDL I MAY / 21
Biperiden or its saltsPDL I DEC / 13
Bisacodyl

when sold in strengths of 5mg or less per oral dosage unit, in package sizes containing no more than 105 mg of bisacodyl

U JUL / 21
Bisacodyl

when sold in strengths of 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl

U JUL / 21
Bisacodyl and its salts

(except when sold in strengths of 5mg or less per oral dosage unit in package sizes containing no more than 105mg of bisacodyl and except when sold in strengths of 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)

III JUL / 21
Bishydroxycoumarin or its salts or derivativesPDL I DEC / 13
Bisoprolol or its saltsPDL I DEC / 13
Bitolterol or its saltsPDL I DEC / 13
BivalirudinPDL I DEC / 13
BleomycinPDL I DEC / 13
BlinatumomabPDL I AUG / 16
Boceprevir or its derivativesPDL I DEC / 13
Boric acid and its salts in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] II DEC / 98
BortezomibPDL I DEC / 13
Bosentan or its salts or derivativesPDL I DEC / 13
Bosutinib or its saltsPDL

including but not limited to Bosutinib methanoate

I AUG / 14
Botulinum toxinPDL

including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A

I DEC / 13
Brentuximab vedotinPDL I DEC / 13
Bretylium tosylatePDL I DEC / 13
Brexpiprazole or its saltsPDL I APR / 17
Brexucabtagene autoleucelPDL I JUL / 21
Brigatinib or its saltsPDL I AUG / 18
Brilliant Blue G or its derivativesPDL I MAY / 21
Brimonidine or its saltsPDL I DEC / 13
Brivaracetam or its derivativesPDL I AUG / 16
BrodalumabPDL I MAY / 18
BrolucizumabPDL I JUL / 20
BromalPDL I DEC / 13
Bromal hydratePDL I DEC / 13
BrometonePDL I DEC / 13
Bromfenac or its saltsPDL I MAY / 15
BromisovalPDL I DEC / 13
Bromocriptine or its saltsPDL I DEC / 13
BromoformPDL I DEC / 13
Brompheniramine and its salts as a single entity for the treatment of allergies III JAN / 03
Brompheniramine and its salts. in combination products for the relief of cough and cold symptoms U JAN / 03
Buclizine II SEP / 98
Bufexamac II SEP / 98
Bumetanide or its salts or derivativesPDL I DEC / 13
Bupivacaine and its salts for parenteral or ophthalmic use II SEP / 98
Bupivacaine and its salts for topical use on mucous membranes except lozenges III SEP / 98
Bupropion or its saltsPDL I DEC / 13
BurosumabPDL I DEC / 18
Buserelin or its saltsPDL I DEC / 13
Buspirone or its saltsPDL I DEC / 13
BusulfanPDL I DEC / 13

106 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act